nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentagastrin—BCHE—diaphragm—amyotrophic lateral sclerosis	0.268	0.36	CbGeAlD
Pentagastrin—CCKBR—nervous system—amyotrophic lateral sclerosis	0.0966	0.13	CbGeAlD
Pentagastrin—CCKBR—central nervous system—amyotrophic lateral sclerosis	0.093	0.125	CbGeAlD
Pentagastrin—CCKBR—cerebellum—amyotrophic lateral sclerosis	0.0909	0.122	CbGeAlD
Pentagastrin—CCKBR—brain—amyotrophic lateral sclerosis	0.0739	0.0993	CbGeAlD
Pentagastrin—CCKBR—Peptide GPCRs—C5AR1—amyotrophic lateral sclerosis	0.0294	0.115	CbGpPWpGaD
Pentagastrin—BCHE—brainstem—amyotrophic lateral sclerosis	0.0287	0.0386	CbGeAlD
Pentagastrin—BCHE—medulla oblongata—amyotrophic lateral sclerosis	0.02	0.0269	CbGeAlD
Pentagastrin—BCHE—Synthesis of PC—CHAT—amyotrophic lateral sclerosis	0.0184	0.0718	CbGpPWpGaD
Pentagastrin—BCHE—spinal cord—amyotrophic lateral sclerosis	0.0178	0.024	CbGeAlD
Pentagastrin—BCHE—nervous system—amyotrophic lateral sclerosis	0.015	0.0202	CbGeAlD
Pentagastrin—BCHE—central nervous system—amyotrophic lateral sclerosis	0.0145	0.0195	CbGeAlD
Pentagastrin—BCHE—cerebellum—amyotrophic lateral sclerosis	0.0142	0.019	CbGeAlD
Pentagastrin—CCKBR—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.0138	0.054	CbGpPWpGaD
Pentagastrin—BCHE—brain—amyotrophic lateral sclerosis	0.0115	0.0154	CbGeAlD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00926	0.0362	CbGpPWpGaD
Pentagastrin—BCHE—Phospholipid metabolism—SACM1L—amyotrophic lateral sclerosis	0.0077	0.0301	CbGpPWpGaD
Pentagastrin—BCHE—Phospholipid metabolism—FIG4—amyotrophic lateral sclerosis	0.00724	0.0283	CbGpPWpGaD
Pentagastrin—BCHE—Glycerophospholipid biosynthesis—PLB1—amyotrophic lateral sclerosis	0.00711	0.0278	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00705	0.0276	CbGpPWpGaD
Pentagastrin—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—amyotrophic lateral sclerosis	0.00674	0.0263	CbGpPWpGaD
Pentagastrin—CCKBR—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.00603	0.0235	CbGpPWpGaD
Pentagastrin—BCHE—Glycerophospholipid biosynthesis—CHAT—amyotrophic lateral sclerosis	0.00539	0.0211	CbGpPWpGaD
Pentagastrin—BCHE—Phospholipid metabolism—PLB1—amyotrophic lateral sclerosis	0.00496	0.0194	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00404	0.0158	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.00399	0.0156	CbGpPWpGaD
Pentagastrin—BCHE—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	0.00376	0.0147	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00369	0.0144	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00362	0.0141	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.0034	0.0133	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.00332	0.013	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00329	0.0128	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.00308	0.012	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00301	0.0117	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00292	0.0114	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00283	0.011	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00282	0.011	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00279	0.0109	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00279	0.0109	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00267	0.0104	CbGpPWpGaD
Pentagastrin—BCHE—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	0.00266	0.0104	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00265	0.0104	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00261	0.0102	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.00252	0.00984	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00252	0.00984	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00252	0.00983	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00249	0.00973	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00248	0.00969	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00244	0.00952	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00233	0.00911	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.0023	0.009	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.0023	0.009	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00216	0.00845	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00214	0.00836	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00214	0.00836	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00214	0.00835	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00191	0.00746	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00191	0.00746	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.00186	0.00727	CbGpPWpGaD
Pentagastrin—BCHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00186	0.00726	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.00179	0.00698	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.00174	0.0068	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.0016	0.00624	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.00158	0.00617	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.00157	0.00614	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00147	0.00574	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00138	0.00538	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.00132	0.00517	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00131	0.00513	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—VAPB—amyotrophic lateral sclerosis	0.0013	0.00507	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—TPK1—amyotrophic lateral sclerosis	0.0013	0.00507	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00121	0.00473	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00119	0.00464	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.00113	0.0044	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.00112	0.00439	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.0011	0.00431	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.00106	0.00413	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00104	0.00406	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—DAO—amyotrophic lateral sclerosis	0.000939	0.00367	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000933	0.00365	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000869	0.00339	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000831	0.00325	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000718	0.00281	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000711	0.00278	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—GSR—amyotrophic lateral sclerosis	0.000657	0.00257	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000598	0.00234	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000553	0.00216	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000539	0.00211	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000522	0.00204	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000492	0.00192	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000469	0.00183	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000354	0.00138	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000351	0.00137	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000337	0.00132	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00029	0.00113	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000266	0.00104	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—APOE—amyotrophic lateral sclerosis	0.000219	0.000856	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.00015	0.000587	CbGpPWpGaD
